Abbott | ABT - Ebitda


Abbott reported $2.43B in EBITDA for its fiscal quarter ending in March of 2026.





Ebitda Change Date
Abbott USD 2.43B 844M Mar/2026
Agilent USD 577M 77M Jun/2026
AtriCure USD 27.28M 10.21M Jun/2026
Baxter International USD 474M 165M Jun/2026
Becton, Dickinson and Co. USD 1.71B 1B Jun/2026
Bio-Rad Laboratories USD 595.3M 1.23B Jun/2026
Boston Scientific USD 1.63B 27M Jun/2026
Cooper Companies USD 67.9M 255.5M Mar/2026
Danaher USD 2.1B 257M Sep/2026
Dexcom USD 435.2M 46.5M Sep/2026
Edwards Lifesciences USD 555.6M 485.5M Mar/2026
Globus Medical USD 279.84M 48.01M Jun/2026
Insulet USD 199.8M 18.1M Jun/2026
Integra LifeSciences USD 79.79M 1.37M Sep/2026
Intuitive Surgical USD 1.2B 147.7M Jun/2026
J&J USD 8.99B 721M Jun/2026
Medtronic USD 2.63B 174M Jun/2026
Merit Medical Systems USD 103.93M 461K Sep/2026
Pfizer USD 6.01B 18M Jun/2026
Smith & Nephew USD 796M 139M Dec/2025
Solventum Corp USD 670M 233M Jun/2026
Stryker USD 1.83B 102M Sep/2026
Tandem Diabetes Care USD 6.42M 3.69M Jun/2026
Teleflex USD 122.91M 47.28M Jun/2026
Terumo JPY 116.67B 58.79B Jun/2026
Thermo Fisher Scientific USD 3.79B 244M Sep/2026
Zimmer Biomet Holdings USD 830.5M 190.4M Jun/2026